MD SB342 | 2019 | Regular Session
Status
Spectrum: Committee Bill
Status: Introduced on January 30 2019 - 25% progression, died in committee
Action: 2019-02-01 - Hearing 2/14 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 30 2019 - 25% progression, died in committee
Action: 2019-02-01 - Hearing 2/14 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring the Prescription Drug Monitoring Program to provide prescription monitoring data to authorized users, rather than the authorized administrator, of another state's prescription drug monitoring program; repealing the termination date of the Program; repealing the requirement that the Department of Legislative Services conduct a certain evaluation of the Program under the Maryland Program Evaluation Act; etc.
Title
Prescription Drug Monitoring Program - Program Evaluation
Sponsors
History
Date | Chamber | Action |
---|---|---|
2019-02-01 | Senate | Hearing 2/14 at 1:00 p.m. |
2019-01-30 | Senate | First Reading Finance |
Subjects
Committees and Commissions
Communications
Data
Discipline
Disclosure
Drugs
Examinations
Health Occupations
Interstate Affairs
Investigations and Inquiries
Law Enforcement
Legislative Services, Department of
Licenses
Penalties and Sentences
Physicians
Public Health
Rules and Regulations
Subpoenas
Sunset
Voting
Communications
Data
Discipline
Disclosure
Drugs
Examinations
Health Occupations
Interstate Affairs
Investigations and Inquiries
Law Enforcement
Legislative Services, Department of
Licenses
Penalties and Sentences
Physicians
Public Health
Rules and Regulations
Subpoenas
Sunset
Voting